SCHEMBL20004372

SCHEMBL20004372

CCCCOC(=O)CC(=O)C(C)(C)c1cccc(OC)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
TSHR P16473 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 2/20 0.36
ATM Q13315 1/20 0.36
MAPT P10636 2/20 0.36
RAB9A P51151 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
LMNA P02545 2/20 0.35
HPGD P15428 1/20 0.35
NPC1 O15118 3/20 0.35
HSD17B10 Q99714 2/20 0.35
TP53 P04637 1/20 0.35
NFKB1 P19838 1/20 0.35
STAT1 P42224 1/20 0.35
NFKB2 Q00653 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL897699 0.81 SORT1 (0.35) TDP1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL10246369 0.76 SORT1 (0.36) TDP1MAPTTP53
SCHEMBL19660083 0.69 AR (0.36)
SCHEMBL28561490 0.68 FAAH (0.49) L3MBTL1TDP1TSHRALDH1A1ATM
SCHEMBL20609556 0.67 AR (0.34)
SCHEMBL20004234 0.67 SMN1; SMN2 (0.39) L3MBTL1TDP1TSHRMEN1KMT2A
SCHEMBL12093711 0.67 HTR7 (0.45) L3MBTL1TSHRMEN1KMT2AALDH1A1
SCHEMBL15661105 0.66 CYP1A2 (0.49) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL19646390 0.66 GRM5 (0.35) TSHRMEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL11937228 0.66 MCHR1 (0.39) L3MBTL1TSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142119-A1 TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-05-11 US disclosed
US-20220306578-A1 TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-09-29 US disclosed
EP-2975024-B1 TETRACYCLIC COMPOUNDS CHUGAI PHARMACEUTICAL CO LTD (JP) 2018-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142119-A1 TETRACYCLIC COMPOUND ALK, TTR, ACVR1 L3MBTL1 200/4885TDP1 361/4885TSHR 1860/4885
US-20220306578-A1 TETRACYCLIC COMPOUND ALK, TTR, ACVR1 L3MBTL1 200/4885TDP1 361/4885TSHR 1860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.